IRIS Accounts Production v24.3.0.553 14497871 director 22.11.22 30.11.23 30.11.23 false true false false true false Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh144978712022-11-21144978712023-11-30144978712022-11-222023-11-30144978712022-11-2114497871ns15:EnglandWales2022-11-222023-11-3014497871ns14:PoundSterling2022-11-222023-11-3014497871ns10:Director12022-11-222023-11-3014497871ns10:PrivateLimitedCompanyLtd2022-11-222023-11-3014497871ns10:SmallEntities2022-11-222023-11-3014497871ns10:AuditExempt-NoAccountantsReport2022-11-222023-11-3014497871ns10:SmallCompaniesRegimeForDirectorsReport2022-11-222023-11-3014497871ns10:SmallCompaniesRegimeForAccounts2022-11-222023-11-3014497871ns10:FullAccounts2022-11-222023-11-3014497871ns10:OrdinaryShareClass12022-11-222023-11-30144978711ns10:OrdinaryShareClass12022-11-222023-11-3014497871ns10:RegisteredOffice2022-11-222023-11-3014497871ns5:CurrentFinancialInstruments2023-11-3014497871ns5:ShareCapital2023-11-3014497871ns5:RetainedEarningsAccumulatedLosses2023-11-3014497871ns5:AdditionsToInvestments2023-11-3014497871ns5:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3014497871ns5:CostValuation2023-11-3014497871ns10:OrdinaryShareClass12023-11-30
REGISTERED NUMBER: 14497871 (England and Wales)















Unaudited Financial Statements

for the Period 22 November 2022 to 30 November 2023

for

SARAH'S NURSERIES LIMITED

SARAH'S NURSERIES LIMITED (REGISTERED NUMBER: 14497871)






Contents of the Financial Statements
for the Period 22 November 2022 to 30 November 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


SARAH'S NURSERIES LIMITED

Company Information
for the Period 22 November 2022 to 30 November 2023







DIRECTOR: S Fox





REGISTERED OFFICE: First Floor
Spitalfields House
Stirling Way
Hertfordshire
WD6 2FX





REGISTERED NUMBER: 14497871 (England and Wales)





ACCOUNTANTS: TC Group
First Floor
Spitalfields House
Stirling Way
Borehamwood
Hertfordshire
WD6 2FX

SARAH'S NURSERIES LIMITED (REGISTERED NUMBER: 14497871)

Balance Sheet
30 November 2023

Notes £   
FIXED ASSETS
Investments 4 2

CURRENT ASSETS
Cash in hand 1

CREDITORS
Amounts falling due within one year 5 (216,890 )
NET CURRENT LIABILITIES (216,889 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(216,887

)

CAPITAL AND RESERVES
Called up share capital 6 1
Retained earnings (216,888 )
SHAREHOLDERS' FUNDS (216,887 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 October 2024 and were signed by:





S Fox - Director


SARAH'S NURSERIES LIMITED (REGISTERED NUMBER: 14497871)

Notes to the Financial Statements
for the Period 22 November 2022 to 30 November 2023

1. STATUTORY INFORMATION

Sarah'S Nurseries Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis as the directors are satisfied that the company will have adequate resources to meet its liabilities to third parties as they fall due.

Preparation of consolidated financial statements
The financial statements contain information about Sarah'S Nurseries Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Significant judgements and estimates
In the application of the company's accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period or in the period of the revision and future periods where the revision affects both current and future periods.

There are no significant judgements or estimates involved in the preparation of the financial statements.

Investments in subsidiaries
Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasure are recognised in the Statement of Comprehensive Income for the period.
Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasure are recognised in profit or loss for the period.

SARAH'S NURSERIES LIMITED (REGISTERED NUMBER: 14497871)

Notes to the Financial Statements - continued
for the Period 22 November 2022 to 30 November 2023

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Schedule 1A of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


SARAH'S NURSERIES LIMITED (REGISTERED NUMBER: 14497871)

Notes to the Financial Statements - continued
for the Period 22 November 2022 to 30 November 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern
The director has considered the company's financial resources and performance and believe that the company is well placed to manage its business risks successfully and that the company has adequate resources to continue in operational existence for the foreseeable future. Consequently, the company continues to adopt the going concern basis of accounting in preparing the annual financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

4. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
Additions 215,039
Impairments (215,037 )
At 30 November 2023 2
NET BOOK VALUE
At 30 November 2023 2

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Amounts owed to group undertakings 42,249
Other creditors 174,641
216,890

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
1 Ordinary £1 1

1 Ordinary share of £1 was allotted and fully paid for cash at par during the period.

SARAH'S NURSERIES LIMITED (REGISTERED NUMBER: 14497871)

Notes to the Financial Statements - continued
for the Period 22 November 2022 to 30 November 2023

7. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.